Develops antiviral therapeutics using a proprietary nanomedicine platform designed to bind to and neutralize viruses. The company’s pipeline focuses on treatments for viral infections such as herpes simplex, influenza, and other emerging pathogens, with programs largely in preclinical or early clini...
1 member of Congress has disclosed 1 trade in NanoViricides, Inc. (NNVC), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2020-04-07 | Kelly Loeffler | sell | $1K – $15K |